The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...

DiffuSphere™, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing ...

On whether the available data supported a clinical benefit, 13 of the 14 panelists said no. Intercept said it will work with ...

Sanofi (SNY) has released an update. Sanofi’s Dupixent has received EU approval as the first treatment for children aged one to 11 with ...

In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...

The investigational monoclonal antibody cendakimab significantly improved symptoms and reduced esophageal eosinophils in ...

New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly esophageal cancer, to find effective strategies to identify patients with this ...

as a treatment of the chronic disease eosinophilic esophagitis. Data describing the pharmacokinetic profile, safety and tolerability of the drug candidate was evaluated between every dose escalation.

New research is exploring low-cost, non-invasive ways to diagnose Barrett's esophagus, a condition associated with deadly ...

There’s no evidence that male enhancement pills can increase penis size, but for people experiencing erectile dysfunction, there are treatment options available. The male enhancement pills ...